All news

Pomerantz probes HCA Healthcare after guidance cut

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Pomerantz LLP has opened an investigation into HCA Healthcare over potential securities fraud or unlawful business practices, after the hospital operator lowered its full-year profit guidance, citing an unfavorable payer mix. HCA Healthcare still posted an 8.70 percent rise in second-quarter revenue to USD 20.23 billion, and shares gained 1.20 percent. The company reports third-quarter results on October 27, which should clarify its financial performance and management's outlook.

Read original source

HCA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.